Pda Tr1 Review

The report provides specific guidance on simulating the partial stoppering, the transfer to the lyophilizer, and even the risks associated with chamber breaks. If you use nitrogen backfill, the report suggests evaluating the sterility of that gas path in your worst-case load configuration. This is a common regulatory citation that TR1 2022 tries to fix. The report is explicit: EM data does not replace APS. Conversely, if you have great EM but fail an APS, the APS overrules the EM.

Here is what you need to know to stay audit-ready. The most significant change in the 2022 revision is the explicit move toward Continuous Process Verification (CPV) . The old TR1 allowed for a bracketing approach where you validated a few worst-case scenarios and called it a day. pda tr1

The new guidance insists that media fills (APS) are not just a regulatory hurdle to cross every six months. They are a living dataset. The report now asks: Are you trending your APS data over time? Are you using statistical process control (SPC) to detect drift before a failure occurs? The report provides specific guidance on simulating the

Beyond the Checklist: What the PDA TR1 (2022 Revision) Means for Your Aseptic Processing The report is explicit: EM data does not replace APS